Akathisia induced by concurrent use of mirogabalin and sulfamethoxazole-trimethoprim: a case report
Abstract Background Mirogabalin and trimethoprim-sulfamethoxazole (TMP/SMX) are frequently used as supportive purpose during and/or after chemotherapy. Mirogabalin is used to treat neuropathic pain, whereas TMP/SMX is used to prevent pneumocystis pneumonia (PCP) in patients who are immunocompromised...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2026-04-01
|
| Ráidu: | Journal of Pharmaceutical Health Care and Sciences |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s40780-026-00578-y |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|